ENZC (Enzolytics) FCF Yield %: -7.22 (As of Jun. 27, 2026)


What is Enzolytics FCF Yield %?

Enzolytics ENZC FCF Yield % is -7.22 as of Jun. 27, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Enzolytics's Trailing 12-Month Free Cash Flow is $-0.35 Mil, and Market Cap is $4.83 Mil. Therefore, Enzolytics's FCF Yield % for today is -7.22%.

The historical rank and industry rank for Enzolytics's FCF Yield % or its related term are showing as below:

ENZC' s FCF Yield % Range Over the Past 10 Years
Min: -9.03   Med: 0   Max: 0
Current: -7.22

ENZC's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -9.715 vs ENZC: -7.22

Enzolytics's FCF Margin % for the quarter that ended in Jun. 2011 was -866.67%.

Enzolytics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Enzolytics FCF Yield % Related Terms

Enzolytics FCF Yield % Historical Data

* Premium members only.

The historical data trend for Enzolytics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics FCF Yield % Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
FCF Yield %
0.00 0.00 -0.10 -5.19

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.64 -8.86 -1.92 -10.77 -16.02

Enzolytics FCF Yield % Competitor Comparison

For the Biotechnology subindustry, Enzolytics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Enzolytics's FCF Yield % falls into.


Enzolytics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Enzolytics's FCF Yield % for the fiscal year that ended in Dec. 2010 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.41 / 7.905
=-5.19%

Enzolytics's annualized FCF Yield % for the quarter that ended in Jun. 2011 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.13 * 4 / 3.245
=-16.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -7.22 mean?
Enzolytics (ENZC) has a FCF Yield % of -7.22 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enzolytics and its competitors.
Is Enzolytics' FCF Yield % too high?
Enzolytics' current FCF Yield % is -7.22.
How does Enzolytics' FCF Yield % compare to competitors?
Enzolytics' FCF Yield % of -7.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enzolytics and its competitors. Enzolytics's current FCF Yield % is -7.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current FCF Yield % of -7.22. The current FCF Yield % is -7.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Enzolytics (ENZC), the current FCF Yield % is -7.22 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.